Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Debt Ratio (2017 - 2025)

United Therapeutics' Debt Ratio history spans 14 years, with the latest figure at 0.03 for Q1 2025.

  • For Q1 2025, Debt Ratio fell 72.04% year-over-year to 0.03; the TTM value through Mar 2025 reached 0.03, down 72.04%, while the annual FY2024 figure was 0.04, 58.29% down from the prior year.
  • Debt Ratio for Q1 2025 was 0.03 at United Therapeutics, down from 0.04 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.17 in Q1 2021 and bottomed at 0.03 in Q1 2025.
  • The 5-year median for Debt Ratio is 0.13 (2023), against an average of 0.12.
  • The largest annual shift saw Debt Ratio decreased 10.72% in 2021 before it tumbled 72.04% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.15 in 2021, then dropped by 14.48% to 0.13 in 2022, then dropped by 26.2% to 0.1 in 2023, then tumbled by 58.29% to 0.04 in 2024, then tumbled by 36.6% to 0.03 in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Debt Ratio are 0.03 (Q1 2025), 0.04 (Q4 2024), and 0.06 (Q3 2024).